Department of General Surgery, Huashan Hospital, Cancer Metastasis Institute, Fudan University, Shanghai, China.
Institutes of Biomedical Sciences, Fudan University, Shanghai, China.
Gut. 2019 Sep;68(9):1653-1666. doi: 10.1136/gutjnl-2019-318419. Epub 2019 Mar 22.
In the tumour microenvironment, critical drivers of immune escape include the oncogenic activity of the tumour cell-intrinsic osteopontin (OPN), the expression of programmed death ligand 1 (PD-L1) and the expansion of tumour-associated macrophages (TAMs). We investigated the feasibility of targeting these pathways as a therapeutic option in hepatocellular carcinoma (HCC) mouse models.
We analysed the number of tumour-infiltrating immune cells and the inflammatory immune profiles in chemically induced liver tumour isolated from wild-type and knockout (KO) mice. In vitro cell cocultures were further conducted to investigate the crosstalk between TAMs and HCC cells mediated by OPN, colony stimulating factor-1 (CSF1) and CSF1 receptor (CSF1R). The in vivo efficacy of anti-PD-L1 and CSF1/CSF1R inhibition was evaluated in OPN overexpressing subcutaneous or orthotopic mouse model of HCC.
The numbers of TAMs, as well as the expression levels of M2 macrophage markers and PD-L1 were significantly decreased, but the levels of cytokines produced by T-helper 1 (Th1) cells were upregulated in tumour tissues from OPN KO mice compared with that from the controls. In addition, we observed a positive association between the OPN and PD-L1 expression, and OPN expression and TAM infiltration in tumour tissues from patients with HCC. We further demonstrated that OPN facilitates chemotactic migration, and alternative activation of macrophages, and promotes the PD-L1 expression in HCC via activation of the CSF1-CSF1R pathway in macrophages. Combining anti-PD-L1 and CSF1R inhibition elicited potent antitumour activity and prolonged survival of OPN tumour-bearing mice. Histological, flow cytometric and ELISA revealed increased CD8 T cell infiltration, reduced TAMs and enhanced Th1/Th2 cytokine balance in multiple mouse models of HCC.
OPN/CSF1/CSF1R axis plays a critical role in the immunosuppressive nature of the HCC microenvironment. Blocking CSF1/CSF1R prevents TAM trafficking and thereby enhances the efficacy of immune checkpoint inhibitors for the treatment of HCC.
在肿瘤微环境中,免疫逃逸的关键驱动因素包括肿瘤细胞内在的骨桥蛋白(OPN)的致癌活性、程序性死亡配体 1(PD-L1)的表达和肿瘤相关巨噬细胞(TAMs)的扩增。我们研究了针对这些途径作为肝细胞癌(HCC)小鼠模型治疗选择的可行性。
我们分析了从野生型和敲除(KO)小鼠中分离的化学诱导肝肿瘤中浸润的免疫细胞数量和炎症免疫特征。进一步进行体外细胞共培养,以研究 OPN、集落刺激因子 1(CSF1)和 CSF1 受体(CSF1R)介导的 TAMs 和 HCC 细胞之间的串扰。在 OPN 过表达的皮下或原位 HCC 小鼠模型中评估抗 PD-L1 和 CSF1/CSF1R 抑制的体内疗效。
与对照相比,OPN KO 小鼠肿瘤组织中的 TAMs 数量以及 M2 巨噬细胞标志物和 PD-L1 的表达水平显著降低,但 Th1 细胞产生的细胞因子水平上调。此外,我们观察到 HCC 患者肿瘤组织中 OPN 表达与 PD-L1 表达之间存在正相关,以及 OPN 表达与 TAM 浸润之间存在正相关。我们进一步证明 OPN 通过激活巨噬细胞中的 CSF1-CSF1R 途径促进趋化性迁移和巨噬细胞的替代激活,并促进 HCC 中的 PD-L1 表达。联合使用抗 PD-L1 和 CSF1R 抑制可增强 OPN 荷瘤小鼠的抗肿瘤活性并延长其生存时间。组织学、流式细胞术和 ELISA 显示,在多种 HCC 小鼠模型中,CD8 T 细胞浸润增加,TAMs 减少,Th1/Th2 细胞因子平衡增强。
OPN/CSF1/CSF1R 轴在 HCC 微环境的免疫抑制性质中起关键作用。阻断 CSF1/CSF1R 可阻止 TAM 转移,从而增强免疫检查点抑制剂治疗 HCC 的疗效。